These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6103816)

  • 1. Antagonist/agonist-preferring alpha-adrenoceptors or alpha 1/alpha 2-adrenoceptors?
    Tanaka T; Starke K
    Eur J Pharmacol; 1980 May; 63(2-3):191-4. PubMed ID: 6103816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics of adrenoceptors in homogenates of human cerebral cortex labelled by (3H)-rauwolscine.
    Summers RJ; Barnett DB; Nahorski SR
    Life Sci; 1983 Sep; 33(11):1105-12. PubMed ID: 6136881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S66-75. PubMed ID: 2414598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
    Howe JR; Yaksh TL
    Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the [3H]-yohimbine binding on rat brain alpha2-adrenoceptors.
    Rouot B; Quennedey MC; Schwartz J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):253-9. PubMed ID: 6300700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of [3H]guanfacine to rat brain alpha-adrenoceptors. Comparison with [3H]clonidine.
    Timmermans PB; Schoop AM; van Zwieten PA
    Biochem Pharmacol; 1982 Mar; 31(6):899-905. PubMed ID: 6282284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
    Schloos J; Wellstein A; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors.
    Cheung YD; Barnett DB; Nahorski SR
    Eur J Pharmacol; 1982 Oct; 84(1-2):79-85. PubMed ID: 6291953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
    Bobik A
    Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes.
    Gross G; Göthert M; Glapa U; Engel G; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):229-35. PubMed ID: 2984581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine.
    Timmermans PB; Schoop AM; Kwa HY; Van Zwieten PA
    Eur J Pharmacol; 1981 Mar; 70(1):7-15. PubMed ID: 6111465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of alpha 2-adrenergic receptors in human fat cell membranes by [3H]chlonidine binding.
    Berlan M; Lafontan M
    Eur J Pharmacol; 1980 Oct; 67(4):481-4. PubMed ID: 6256178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.